Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


U.S. Places Big H1N1 Vaccine Order With Australia’s CSL

This article was originally published in PharmAsia News

Executive Summary

Australia's CSL has received a $142 million order for H1N1 flu vaccine expected to be ready for inoculations in October. The order from the United States, where 12 deaths have been attributed to the disease, includes U.S. funding for clinical trials for the Novel A version of the disease in bulk form. CSL received an order for 10 million doses from the Australian government just days before. (Click here for more

Related Content




Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts